NSC |
Compound |
Enrichment |
Correlation |
NSC 751382 |
N-(3-((2,5-dimethylbenzyl)oxy)-4-(N-methylmethylsulfonamido)phenyl)-2,3-dihydro-1H-indene-5-carboxamide |
0.0133986477026051 |
0.21751572 |
NSC 754329 |
Null |
0.0133986477026051 |
0.21122258 |
NSC 755413 |
Null |
0.0133986477026051 |
0.35700903 |
NSC 763275 |
(E)-8-(4-chlorobenzylidene)-4-(4-chlorophenyl)-3,4,5,6,7,8-hexahydroquinazolin-2-amine |
0.0133986477026051 |
0.15485041 |
NSC 764090 |
BMS-777607 |
0.0133986477026051 |
-0.074855954 |
NSC 15200 |
WLN: GA N-O3*3 |
0.0133986477026052 |
-0.2700554 |
NSC 225112 |
2,4,6-Quinazolinetriamine, N(6)-[(3,4-dichlorophenyl)methyl]-N(6)-ethyl-5-methyl- |
0.0133986477026052 |
0.43932752 |
NSC 266047 |
1,2-Cyclohexanediamine, platinum complex, (1R-trans)- (9CI) |
0.0133986477026052 |
0.61531378 |
NSC 3082 |
s-Triazine, 4,6-diamino-1-(m-bromophenyl)-1,2-dihydro-2,2-dimethyl-, hydrochloride (8CI) |
0.0133986477026052 |
0.47515349 |
NSC 373355 |
Saframycin R |
0.0133986477026052 |
0.15194885 |